Opticyte - The World’s Only Cell O₂ Monitor

Opticyte Seeks Final Investors as StartEngine Campaign Nears Close after $235,000+ Raised; VitalO₂ Targets Earlier Hypoxia Detection and Racial Bias in Oximetry

Opticyte is in the final month of its StartEngine raise, having secured over $235,000 on the platform plus additional convertible-note investment, and is inviting new investors to support its VitalO₂ Monitor aimed at earlier oxygen deficiency detection and reducing pulse oximetry racial disparities.